Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection

Michael Kaleko, Sheila Connelly, Steven Hubert et al.|Anaerobe|2016

Cited by 71